Stay updated with breaking news from Real World Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There are many options to try for patients if one therapy doesn’t work, but there are challenges around getting new treatments into the clinic, said Joshua Meeks, MD, PhD, of Northwestern University Feinberg School of Medicine.
Hope Rugo, MD, FASCO, and Naomi Dempsey, MD, examine the NCCN guidelines compared to real-world evidence, particularly in the treatment of menopausal, pre-menopausal, and high-risk early-stage HR+/HER2- patients.
Explore the complexities of limited molecular genotyping availability, the importance of comprehensive testing, and challenges in accessing target therapies, including cost considerations, in real-world clinical practice.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
BRIDGEWATER, N.J., July 19, 2021 – Bausch + Lomb, a leading global eye health business, today announced the presentation of 14 scientific posters involving the company’s ophthalmic surgical technologies at the American Society of Cataract and Refractive Surgery annual meeting, which will take place from July 23-27, 2021, in Las Vegas. “We are always pleased to have surgeons sharing new scientific findings related to our products,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “The presentation of this data helps clinicians learn ...